Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

261. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial (...) . Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation. Health Technology Assessment 2015; 19(16) Authors' objectives To (1) evaluate whether or not low-dose corticosteroids given as an adjunct to standard treatment is beneficial in patients who are hospitalised with severe pandemic influenza and (2) develop an 'off-the-shelf' clinical trial that is ready to be activated

2015 Health Technology Assessment (HTA) Database.

262. Interventions effective in increasing influenza vaccination rates

Interventions effective in increasing influenza vaccination rates Interventions effective in increasing influenza vaccination rates | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective in increasing influenza vaccination rates Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2015 Cochrane PEARLS

263. Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Full Text available with Trip Pro

Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find

2015 NIHR HTA programme

264. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness. Full Text available with Trip Pro

Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness. Influenza is a highly infectious viral disease that is particularly common in the winter months. Oscillococcinum® is a patented homeopathic medicine that is made from a 1% solution of wild duck heart and liver extract, which is then serially diluted 200 times with water and alcohol.To determine whether homeopathic Oscillococcinum® is more effective than placebo in the prevention and/or treatment (...) of influenza and influenza-like illness in adults or children.We searched CENTRAL (2014, Issue 8), MEDLINE (1966 to August week 4, 2014), MEDLINE In-Process & Other Non-Indexed Citations (4 September 2014), AMED (2006 to September 2014), Web of Science (1985 to September 2014), LILACS (1985 to September 2014) and EMBASE (1980 to September 2014). We contacted the manufacturers of Oscillococcinum® for information on further trials.Randomised, placebo-controlled trials of Oscillococcinum® in the prevention

2015 Cochrane

265. Occurrence of cardiovascular events in patients with coronary artery disease receiving the influenza vaccine

Occurrence of cardiovascular events in patients with coronary artery disease receiving the influenza vaccine "Occurrence of cardiovascular events in patients with coronary artery d" by Dilpreet Bal < > > > > > Title Author Date of Graduation Summer 8-8-2015 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Saje Davis-Risen, MS, PA-C Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: Cardiovascular disease (...) is the leading cause of death worldwide with coronary artery disease (CAD) making up a majority of those deaths. Coronary artery diseases are atherosclerotic or thrombotic in nature leading to a disparity of blood in the coronary arteries and subsequent infarction of heart muscle. Influenza has been established as a pro-inflammatory agent that has been implicated in increased death rates from cardiovascular disease. With the establishment of this causal relationship, several trials were run to assess

2015 Pacific University EBM Capstone Project

266. The duration of serological protection against seasonal influenza vaccination in the elderly: a systematic review

The duration of serological protection against seasonal influenza vaccination in the elderly: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

267. Parental knowledge, attitudes and practices concerning influenza vaccines for children: a systematic review

Parental knowledge, attitudes and practices concerning influenza vaccines for children: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2015 PROSPERO

268. Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults [Cochrane Protocol]

Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

269. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease [Cochrane Protocol]

Conjugate Haemophilus influenzae type b vaccines for sickle cell disease [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2015 PROSPERO

270. Effectiveness and safety of oseltamivir for treating influenza: an overview of systematic reviews

Effectiveness and safety of oseltamivir for treating influenza: an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2015 PROSPERO

271. The roles of transportation and transportation hubs in the propagation of influenza and coronaviruses: a systematic review

The roles of transportation and transportation hubs in the propagation of influenza and coronaviruses: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

272. Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review

Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2015 PROSPERO

273. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective

Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Ting E, Ungar WJ Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Ting E, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective. Toronto, ON: Technology Assessment at SickKids (TASK). 2015 Authors' conclusions From the societal perspective and in many cases the health care system perspective as well, seasonal influenza vaccination was generally found to be a cost-effective strategy. Vaccinating all pregnant and postpartum women against seasonal influenza compared

2015 Health Technology Assessment (HTA) Database.

274. Arbidol for preventing and treating influenza in adults and children [Cochrane Protocol]

Arbidol for preventing and treating influenza in adults and children [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2015 PROSPERO

275. A systematic review of accuracy of rapid influenza diagnostic tests

A systematic review of accuracy of rapid influenza diagnostic tests Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2015 PROSPERO

276. Use of neuraminidase inhibitors in influenza

Use of neuraminidase inhibitors in influenza Improving School Governance | 1 Use of neuraminidase inhibitors in influenza Image: Swine Flu virus Sculpture Luke Jerram/Wellcome Images October 2015 1 Use of Neuraminidase Inhibitors in Influenza Contents 1. Summary Background Commentary on the recent publications Pipeline of new drugs and resistance Research priorities Preparedness 3 2. Introduction Terms of reference and conduct of this review Current influenza guidelines 6 3. Studies considered (...) in this report 10 4. Strengths and limitations of the studies considered Quality of evidence Individual patient data and study level analyses Lack of completeness of data Conflicts of interest and transparency 13 5. Synthesis of evidence and implications a) Treatment for any previously healthy people with influenza that is not (currently) severe (‘treat all’ approach) b) Treatment for previously healthy people who develop severe influenza c) Commencing treatment in severely ill individuals more than 48 hours

2015 Academy of Medical Sciences

277. Fluenz Tetra - seasonal influenza in children

Fluenz Tetra - seasonal influenza in children FLUENZTETRA SUMMARY CT13920

2015 Haute Autorite de sante

278. Systematic review of the cost-effectiveness of influenza immunization programs: A Canadian perspective

Systematic review of the cost-effectiveness of influenza immunization programs: A Canadian perspective The Hospital for Sick Children Technology Assessment at SickKids (TASK) FULL REPORT SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF INFLUENZA IMMUNIZATION PROGRAMS: A CANADIAN PERSPECTIVE Author: Eon Ting, BSc, MBA, MSc Supervisor and Senior Responsible Author: Wendy J. Ungar, MSc, PhD Child Health Evaluative Sciences, The Hospital for Sick Children Corresponding Author: Wendy J. Ungar, MSc (...) are the views of the authors and do not necessarily reflect those of The Hospital for Sick Children, Public Health Ontario, or the province of Ontario. CONFLICTS OF INTEREST During the timing of writing this technical report, ET was an employee of AstraZeneca Canada. ii Abstract In Canada, currently no national seasonal influenza immunization program exists. To better inform policy, the cost-effectiveness of influenza immunization programs was examined. Using a best-evidence synthesis approach, 31 economic

2015 SickKids Reports

279. Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Full Text available with Trip Pro

Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Zanamivir for influenza in adults and children shows

2015 Evidence-Based Medicine

280. No evidence for benefits of influenza vaccine in institutional healthcare workers

No evidence for benefits of influenza vaccine in institutional healthcare workers No evidence for benefits of influenza vaccine in institutional healthcare workers | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms No evidence for benefits of influenza vaccine in institutional healthcare workers Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS